LivaNova Deutschland GmbH

LivaNova Deutschland GmbH is part of LivaNova, a global medical technology company that develops products and therapies for the head and heart. Its portfolio spans advanced circulatory support and cardiopulmonary products, VNS Therapy (vagus nerve stimulation for drug-resistant epilepsy and difficult-to-treat depression), and solutions for obstructive sleep apnea. The work sits at the intersection of several technical domains: medical devices, neuromodulation, cardiopulmonary and circulatory support technology, and sleep medicine.

The company operates in more than 100 countries and employs nearly 4,000 people, drawn from more than 70 nationalities. It brings decades of experience to cardiac and neurological health innovation, working across industries that include cardiology, neurology, mental health and sleep medicine.

LivaNova describes its culture as mission-driven, with a stated commitment to patients and a view of its work as one where lives depend on the outcome. The stated ambition is to alter the course of patients' lives rather than merely treat conditions, and to focus health innovation on areas where it matters most.